Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 11/20 | 0.35 |
| ▸ | F10 | P00742 | 7/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 3/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7923391 | 1.00 | MET (0.40) | METGRM2F10NR1I2KCNH2 | |
| SCHEMBL7921780 | 0.93 | MET (0.40) | METGRM2F10NR1I2KCNH2 | |
| SCHEMBL6224791 | 0.93 | MET (0.40) | METGRM2F10NR1I2KCNH2 | |
| Trifluoroacetic Acid SCHEMBL7220554 | 0.93 | MET (0.38) | METGRM2F10F2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL7923392 | 0.89 | F10 (0.36) | METGRM2F10NR1I2KCNH2 | |
| Trifluoroacetic Acid SCHEMBL6220784 | 0.87 | F10 (0.46) | METF10 | |
| Trifluoroacetic Acid SCHEMBL7409145 | 0.87 | F10 (0.46) | METF10 | |
| SCHEMBL7921803 | 0.85 | SMYD3 (0.40) | METF10F2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL7214503 | 0.85 | F10 (0.47) | F10KCNH2F2 | |
| Trifluoroacetic Acid SCHEMBL7213654 | 0.83 | F10 (0.47) | METF10F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6281227-B1 | INHIBITORS OF THE ACTIVITY OF FACTOR XA. | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-08-28 | — | — | US | claimed |
| US-6281227-B1 | INHIBITORS OF THE ACTIVITY OF FACTOR XA. | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-08-28 | — | — | US | disclosed |